Log in

NYSE:PBH - Prestige Consumer Healthcare Stock Price, Forecast & News

$40.76
-1.64 (-3.87 %)
(As of 02/25/2020 01:36 AM ET)
Today's Range
$40.24
Now: $40.76
$41.73
50-Day Range
$38.41
MA: $41.70
$45.96
52-Week Range
$26.49
Now: $40.76
$46.12
Volume325,720 shs
Average Volume412,004 shs
Market Capitalization$2.05 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.94
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPersonal Products
SectorConsumer Discretionary
CUSIP74112D10
Phone914-524-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$975.78 million
Cash Flow$3.41 per share
Book Value$21.16 per share

Profitability

Net Income$-35,800,000.00

Miscellaneous

Employees530
Market Cap$2.05 billion
Next Earnings Date5/14/2020 (Estimated)
OptionableOptionable

Receive PBH News and Ratings via Email

Sign-up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.


Prestige Consumer Healthcare (NYSE:PBH) Frequently Asked Questions

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc (NYSE:PBH) issued its quarterly earnings data on Thursday, February, 6th. The company reported $0.81 EPS for the quarter, topping the Zacks' consensus estimate of $0.75 by $0.06. The company had revenue of $241.60 million for the quarter, compared to analysts' expectations of $240.34 million. Prestige Consumer Healthcare had a positive return on equity of 13.17% and a negative net margin of 3.57%. The firm's quarterly revenue was up .1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.73 earnings per share. View Prestige Consumer Healthcare's Earnings History.

When is Prestige Consumer Healthcare's next earnings date?

Prestige Consumer Healthcare is scheduled to release their next quarterly earnings announcement on Thursday, May 14th 2020. View Earnings Estimates for Prestige Consumer Healthcare.

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare issued an update on its FY20 earnings guidance on Thursday, February, 6th. The company provided earnings per share (EPS) guidance of $2.85-2.87 for the period, compared to the Thomson Reuters consensus estimate of $2.82. The company issued revenue guidance of $947-957 million, compared to the consensus revenue estimate of $950.04 million.

What price target have analysts set for PBH?

4 analysts have issued 1 year price objectives for Prestige Consumer Healthcare's stock. Their forecasts range from $84.00 to $106.00. On average, they anticipate Prestige Consumer Healthcare's share price to reach $95.67 in the next year. This suggests a possible upside of 134.7% from the stock's current price. View Analyst Price Targets for Prestige Consumer Healthcare.

What is the consensus analysts' recommendation for Prestige Consumer Healthcare?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Prestige Consumer Healthcare.

Has Prestige Consumer Healthcare been receiving favorable news coverage?

News coverage about PBH stock has trended neutral recently, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Prestige Consumer Healthcare earned a daily sentiment score of 0.4 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 9.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Prestige Consumer Healthcare.

Who are some of Prestige Consumer Healthcare's key competitors?

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Gilead Sciences (GILD), AbbVie (ABBV), Cara Therapeutics (CARA), GW Pharmaceuticals PLC- (GWPH), Rigel Pharmaceuticals (RIGL), Johnson & Johnson (JNJ), Marathon Petroleum (MPC), Pfizer (PFE), AT&T (T) and Wells Fargo & Co (WFC).

Who are Prestige Consumer Healthcare's key executives?

Prestige Consumer Healthcare's management team includes the folowing people:
  • Mr. Ronald M. Lombardi, Chairman, Pres & CEO (Age 55)
  • Ms. Christine Sacco, Chief Financial Officer (Age 43)
  • Mr. William C. P'Pool, Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Mr. Timothy J. Connors, Exec. VP of Sales & Marketing (Age 52)
  • Mr. Jeff Zerillo, Sr. VP of Operations

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by a number of of retail and institutional investors. Top institutional investors include Champlain Investment Partners LLC (4.73%), FMR LLC (3.79%), ArrowMark Colorado Holdings LLC (3.70%), State Street Corp (3.54%), Goldman Sachs Group Inc. (3.46%) and Acadian Asset Management LLC (2.85%). Company insiders that own Prestige Consumer Healthcare stock include Jean A Boyko, Paton Brett and Timothy Connors. View Institutional Ownership Trends for Prestige Consumer Healthcare.

Which institutional investors are selling Prestige Consumer Healthcare stock?

PBH stock was sold by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, Goldman Sachs Group Inc., Acadian Asset Management LLC, State of Tennessee Treasury Department, Prudential Financial Inc., Lapides Asset Management LLC, Oxford Asset Management LLP and Skyline Asset Management LP. View Insider Buying and Selling for Prestige Consumer Healthcare.

Which institutional investors are buying Prestige Consumer Healthcare stock?

PBH stock was purchased by a variety of institutional investors in the last quarter, including Champlain Investment Partners LLC, Wedge Capital Management L L P NC, Man Group plc, Peregrine Capital Management LLC, Massachusetts Financial Services Co. MA, Martingale Asset Management L P, Turtle Creek Asset Management Inc. and LSV Asset Management. View Insider Buying and Selling for Prestige Consumer Healthcare.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $40.76.

How big of a company is Prestige Consumer Healthcare?

Prestige Consumer Healthcare has a market capitalization of $2.05 billion and generates $975.78 million in revenue each year. The company earns $-35,800,000.00 in net income (profit) each year or $2.78 on an earnings per share basis. Prestige Consumer Healthcare employs 530 workers across the globe.View Additional Information About Prestige Consumer Healthcare.

What is Prestige Consumer Healthcare's official website?

The official website for Prestige Consumer Healthcare is http://www.prestigebrands.com/.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected]


MarketBeat Community Rating for Prestige Consumer Healthcare (NYSE PBH)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  448 (Vote Outperform)
Underperform Votes:  333 (Vote Underperform)
Total Votes:  781
MarketBeat's community ratings are surveys of what our community members think about Prestige Consumer Healthcare and other stocks. Vote "Outperform" if you believe PBH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel